MedPage Today on MSN
New Agents for AMD Preserve Vision, Dramatically Reduce Treatment Burden
Bispecific antibody fares well against faricimab, two gene therapies extend treatment inte ...
MarketBeat on MSN
Belite Bio conference highlights tinlarebant data and new hope for retinal diseases
Key Points Interested in Belite Bio, Inc. Sponsored ADR? Here are five stocks we like better. Belite Bio highlighted positive ...
Vonaprument reduced the proportion of eyes with clinically meaningful vision loss, though not uniformly across doses. Through ...
K8 slowed disease progression and trended towards improving visual acuity, which Inflammasome says warrants the drug’s further evaluation.
Bausch + Lomb announced topline results from its phase 2 study of BL1107 in patients with glaucoma. According to the company, ...
It’s a fine measure of the curator Joel Smith’s visual and emotional acuity that the first standout images one encounters on ...
Children exposed to opioids before birth may face increased risks of difficulties with vision, attention, behavior and ...
After a single intravitreal dose of 4D-150, visual acuity and anatomic control was maintained with consistent and durable treatment burden reduction through 2 years 4D-150 continues to be well tolerat ...
Key Points Interested in Surrozen, Inc.? Here are five stocks we like better. Surrozen is advancing a Wnt-based retina ...
July 17, 2026 - PRESSADVANTAGE - A new article published by PES Adult Strabismus Center, titled Adult Strabismus and ...
A recent study found that regular cultural engagement, such as attending the cinema, theater, or museums, may help slow ...
Presenters at the ASRS evaluated visual and anatomical outcomes in patients with idiopathic epiretinal membranes undergoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results